Pergolide: long-term use in Parkinson's disease (Q70216125)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 October 1988

edit

Language	Label	Description	Also known as
English	Pergolide: long-term use in Parkinson's disease	scientific article published on 01 October 1988

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3050301

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3050301%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 October 2019

title

Pergolide: long-term use in Parkinson's disease (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3050301

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3050301%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 October 2019

main subject

Parkinson's disease

1 reference

based on heuristic

inferred from title

author

J Eric Ahlskog

series ordinal

1

object named as

J E Ahlskog

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3050301

retrieved

9 October 2019

author name string

M D Muenter

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3050301

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3050301%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 October 2019

publication date

1 October 1988

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3050301

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3050301%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 October 2019

published in

Mayo Clin Proc

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3050301

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3050301%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 October 2019

volume

63

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3050301

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3050301%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 October 2019

issue

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3050301

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3050301%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 October 2019

page(s)

979-987

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3050301

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3050301%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 October 2019

cites work

Five years' treatment of Parkinson's disease with levodopa. Therapeutic results and survival of 100 patients

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964912-X

retrieved

7 January 2021

Success and problems of long-term levodopa therapy in Parkinson's disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964912-X

retrieved

7 January 2021

Long-term follow-up of early dopa treatment in Parkinson's disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964912-X

retrieved

7 January 2021

Controlled trial of pergolide mesylate in Parkinson's disease and progressive supranuclear palsy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964912-X

retrieved

7 January 2021

Double-blind trial of pergolide for Parkinson's disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964912-X

retrieved

7 January 2021

Treatment of Parkinson's disease with pergolide: a double-blind study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964912-X

retrieved

7 January 2021

Long-term study of pergolide in Parkinson's disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964912-X

retrieved

7 January 2021

Parkinsonism: onset, progression, and mortality

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964912-X

retrieved

7 January 2021

Does long-term aggravation of Parkinson's disease result from nondopaminergic lesions?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964912-X

retrieved

7 January 2021

Neurotransmitter receptor alterations in Parkinson's disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964912-X

retrieved

7 January 2021

Receptor basis for dopaminergic supersensitivity in Parkinson's disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964912-X

retrieved

7 January 2021

Dopamine agonists reverse the elevated 3H-neuroleptic binding in neuroleptic-pretreated rats

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964912-X

retrieved

7 January 2021

Dopamine receptor agonists: intrinsic activity vs. state of receptor

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964912-X

retrieved

7 January 2021

Chronic levodopa or pergolide administration induces down-regulation of dopamine receptors in denervated striatum

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964912-X

retrieved

7 January 2021

Altered pharmacokinetics of L-dopa metabolism in rat striatum deprived of dopaminergic innervation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964912-X

retrieved

7 January 2021

On-off phenomenon: relation to levodopa pharmacokinetics and pharmacodynamics

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964912-X

retrieved

7 January 2021

Q64762166

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964912-X

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

"On-off" effects in patients with Parkinson's disease on chronic levodopa therapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964912-X

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1016/S0025-6196(12)64912-X

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3050301

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3050301%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 October 2019

PubMed publication ID

3050301

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3050301

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3050301%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 October 2019

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q70216125&oldid=2232422734"